QUICK SEARCH:   [advanced] Author: Keyword(s): Year:  Vol:  Page:

This Article Full Text Full Text (PDF) All Versions of this Article: dmd.106.013607v1 35/9/1518    most recent Submit a response Alert me when this article is cited Alert me when eLetters are posted Alert me if a correction is posted Services Similar articles in this journal Similar articles in PubMed Alert me to new issues of the journal Download to citation manager Citing Articles Citing Articles via HighWire Citing Articles via Google Scholar Google Scholar Articles by Yoon, Y.-J. Articles by Shin, J.-G. Search for Related Content PubMed PubMed Citation Articles by Yoon, Y.-J. Articles by Shin, J.-G.

Characterization of Benidipine and Its Enantiomers' Metabolism by Human Liver Cytochrome P450 Enzymes

Department of Pharmacology and PharmacoGenomics Research Center, Inje University College of Medicine, Busan, Korea (Y.-J.Y., K.-B.K., H.K., K.-A.S., H.-S.K., I.-J.C., K.-H.L., J.-G.S.); Department of Clinical Pharmacology, Inje University Busan Paik Hospital, Busan, Korea (E.-Y.K., J.-G.S.); and Frontier Inje Research for Science and Technology, Inje University, Busan, Korea (K.-H.L.)

Benidipine is a dihydropyridine calcium antagonist that has been used clinically as an antihypertensive and antianginal agent. It is used clinically as a racemate, containing the (-)- and (+)- isomers of benidipine. This study was performed to elucidate the metabolism of benidipine and its enantiomers in human liver microsomes (HLMs) and to characterize the cytochrome P450 (P450) enzymes that are involved in the metabolism of benidipine. Human liver microsomal incubation of benidipine in the presence of NADPH resulted in the formation of two metabolites, N-desbenzylbenidipine and dehydrobenidipine. The intrinsic clearance (CL_int) of the formation of N-desbenzylbenidipine and dehydrobenidipine metabolites from (-)- isomer was similar to those from the (+)- isomer (1.9 ± 0.1 versus 2.3 ± 2.3 µl/min/pmol P450 and 0.5 ± 0.2 versus 0.6 ± 0.6 µl/min/pmol P450, respectively). Correlation analysis between the known P450 enzyme activities and the rate of the formation of benidipine metabolites in the 15 HLMs showed that benidipine metabolism is correlated with CYP3A activity. The P450 isoform-selective inhibition study in liver microsomes and the incubation study of cDNA-expressed enzymes also showed that theN-debenzylation and dehydrogenation of benidipine are mainly mediated by CYP3A4 and CYP3A5. The total CL_int values of CYP3A4-mediated metabolite formation from (-)- isomer were similar to those from (+)- isomer (17.7 versus 14.4 µl/min/pmol P450, respectively). The total CL_int values of CYP3A5-mediated metabolite formation from (-)- isomer were also similar to those from (+)- isomer (8.3 versus 11.0 µl/min/pmol P450, respectively). These findings suggest that CYP3A4 and CYP3A5 isoforms are major enzymes contributing to the disposition of benidipine, but stereoselective disposition of benidipine in vivo may be influenced not by stereoselective metabolism but by other factors.

This article has been cited by other articles:

				S. K. Bae, S. Cao, K.-A. Seo, H. Kim, M.-J. Kim, J.-H. Shon, K.-H. Liu, H.-H. Zhou, and J.-G. Shin Cytochrome P450 2B6 Catalyzes the Formation of Pharmacologically Active Sibutramine (N-{1-[1-(4-chlorophenyl)cyclobutyl]-3-methylbutyl}-N,N-dimethylamine) Metabolites in Human Liver Microsomes Drug Metab. Dispos., August 1, 2008; 36(8): 1679 - 1688. [Abstract] [Full Text] [PDF]